Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hak Choy, MD"'
Autor:
Eric J. Hsu, PhD, Jameson T. Mendel, MD, Kristin A. Ward, MD, Mariam El-Ashmawy, MD, Minjae Lee, PhD, Hak Choy, MD, Kenneth D. Westover, MD, PhD, Dat T. Vo, MD, PhD, Robert D. Timmerman, MD, David J. Sher, MD, Puneeth Iyengar, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 5, Pp 100995- (2022)
Purpose: : Five-fraction stereotactic ablative radiotherapy (SABR) regimens are frequently used to treat centrally located early-stage non-small cell lung cancer or disease in the proximity of the chest wall as a means of optimizing tumor control and
Externí odkaz:
https://doaj.org/article/b74d8f81cb8a41bfa5b27c2798aa74a3
Autor:
Jonathan E. Schoenhals, BS, Osama Mohamad, MD, PhD, Alana Christie, MS, Yuanyuan Zhang, MD, PhD, Daniel Li, MD, Nirmish Singla, MD, MSCS, Isaac Bowman, MD, Waddah Arafat, MD, Hans Hammers, MD, Kevin Courtney, MD, PhD, Suzanne Cole, MD, Aditya Bagrodia, MD, Vitaly Margulis, MD, Neil Desai, MD, Aurelie Garant, MD, Hak Choy, MD, Robert Timmerman, MD, James Brugarolas, MD, PhD, Raquibul Hannan, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100692- (2021)
Purpose: Oligoprogression, defined as limited sites of progression on systemic therapy, in patients with metastatic renal cell carcinoma (mRCC) is not uncommon, possibly because of inter- and intratumoral heterogeneity. We evaluated the effect of ste
Externí odkaz:
https://doaj.org/article/d3d6725df09840e68eee2bfa7aa552b3